Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (5165)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jun 16, 2024 (publication date) through Dec 4, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Chai WH, Ma Y, Li JJ, Guo F, Wu YZ, Liu JW. Immune cell signatures and causal association with irritable bowel syndrome: A mendelian randomization study. World J Clin Cases 2024; 12(17): 3094-3104 [PMID: 38898868 DOI: 10.12998/wjcc.v12.i17.3094] |
|
|
|
| ©2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA | |
| For: | Chai WH, Ma Y, Li JJ, Guo F, Wu YZ, Liu JW. Immune cell signatures and causal association with irritable bowel syndrome: A mendelian randomization study. World J Clin Cases 2024; 12(17): 3094-3104 [PMID: 38898868 DOI: 10.12998/wjcc.v12.i17.3094] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v12/i17/3094.htm |
| Number | Citing Articles |
| 1 |
Deepak Chandra Joshi, Neha Raina, Nirmal Joshi, Kajal Gurow, Jyoti Gwasakoti, Abhilasha Sood, Arpit Mehrotra, Hardeep Singh Tuli, Keshav Raj Paudel, Madhu Gupta. Current Landscape of Novel Therapeutic Agents and Drug Targets in Irritable Bowel Syndrome. Archiv der Pharmazie 2025; 358(11) doi: 10.1002/ardp.70133
|
| 2 |
Yizhan Wu, Fei Guo, Xiaoxia Xu, Ya Liu, Jiangwei Liu, Jasbir Arora (RSS). Based on Proteomics Data Revealing the Potential of Traditional Chinese Medicine in Treating Irritable Bowel Syndrome. Mediators of Inflammation 2025; 2025(1) doi: 10.1155/mi/7748351
|
| 3 |
Xuemeng Wan, Liyuan Wang, Zhiling Wang, Chaomin Wan. Toll-like receptor 4 plays a vital role in irritable bowel syndrome: a scoping review. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1490653
|